The emerging molecular machinery and therapeutic targets of metastasis

Yutong Sun1, Li Ma2

  • 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Insights

Metastasis research has advanced, yet it remains a major cause of cancer death. Overcoming obstacles requires understanding molecular mechanisms and developing new preventive drugs and therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Metastasis is a complex, century-old research area.
  • Despite technological advances, metastasis remains the primary cause of cancer mortality.
  • Significant obstacles hinder metastasis prevention and treatment, including a lack of clinical trials for preventive drugs and incomplete knowledge of underlying molecular mechanisms.

Purpose of the Study:

  • To review recent progress in metastasis research.
  • To highlight key areas of investigation in understanding cancer spread.
  • To identify emerging therapeutic targets and challenges in metastasis treatment.

Main Methods:

  • Literature review of recent advancements in metastasis research.
  • Discussion of key biological processes involved in cancer metastasis.
  • Analysis of molecular determinants and signaling pathways regulating metastasis.

Main Results:

  • Epithelial-mesenchymal plasticity is a critical factor in metastasis.
  • Cancer stem cells play a significant role in tumor spread and recurrence.
  • Emerging molecular determinants and therapeutic targets are being identified.
  • A strong link exists between metastasis and therapy resistance.

Conclusions:

  • Continued research into molecular mechanisms is crucial for effective metastasis prevention and treatment.
  • Addressing the lack of clinical trials for preventive drugs is essential.
  • Understanding the interplay between metastasis and therapy resistance can guide novel therapeutic strategies.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K